Search

A new report says that ovarian cancer research is improving, but more needs to be done, especially with regards to screening at an early stage. Also, where patients receive care makes a big difference in their outcome.

A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.

As a financial services specialist at MSK, Charlene Jerome helps patients overcome financial barriers to treatment by hunting for free drugs, deep discounts, and financial aid so patients can focus on healing.

Of the estimated 1.5 million people diagnosed with cancer each year in the United States, more than 126,000 are between the ages of 20 and 45. Many young cancer patients want to have children after their treatment is completed, and many will be able to have children naturally at that time. However, some patients will lose their ability to conceive a child without the help of procedures designed to assist with reproduction. Unfortunately, many young patients are not adequately informed of and prepared for the risks to fertility that may accompany cancer and some cancer treatments.

An international collaboration of researchers is advancing precision medicine for men with advanced prostate cancer.

Memorial Sloan Kettering Cancer Center (MSK) experts presented breakthrough findings in several areas of cancer research at the 2022 Annual ASCO meeting, focusing on rectal, breast, leptomeningeal metastasis, pancreatic, and lung cancers.

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.